Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning... ( SHANGHAI Dec. 1 Asia/ -- Sha...)

Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies

Date:12/1/2009

SHANGHAI, Dec. 1 /PRNewswire-Asia/ -- Shanghai ChemPartner, as the flagship subsidiary of ShangPharma, a leading China-based Contract Research Organization (CRO), today announced it is a winner of the 2009 Deloitte Technology Fast 50 China, ranking 3rd on the list of the fastest-growing high tech companies in China. The award is a testament to ChemPartner's outstanding three-year revenue growth from 2006 to 2008.

The results of the 2009 Deloitte Technology Fast 50 China Program were officially released at an award presentation ceremony in Beijing. ChemPartner was the only company from the pharmaceutical and healthcare sector in the Top 10 ranking.

"We are quite honored to be presented this award by Deloitte, which is a globally acknowledged independent professional agency and consulting partner," said Michael Hui, founder and CEO of Shanghai ChemPartner. "This is a remarkable recognition to our consistent efforts in strategically expanding and consolidating our R&D service portfolio, sharpening our core competence through improving internal operation efficiency."

"We will keep focusing more on our own development such as further optimizing operational efficiency and attracting and retaining talent. Developing business in this uncertain economic environment has taught us the importance of successful risk management; and we believe that improving productivity through careful strategic planning and innovation can help companies achieve sustainable growth." Michael Hui added.

Mr. William Chou, Deloitte China's National Leader of Technology, Media & Telecommunications, said, "Backed by the country's strong economic expansion and government support for technological innovation, there is still much room for the Chinese hi-tech industry to grow. Significant overseas and domestic investments in innovative and growing Chinese companies are also driving industry development. It has been
'/>"/>

SOURCE Shanghai ChemPartner Company Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Pharma and Biotech Leaders to Converge in Shanghai
2. Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level
3. Sundia Shortens CRO Shipment Delivery Time with Express Customs Clearance in Shanghai
4. Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration
5. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
6. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
7. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
8. Carna Biosciences Signs Distribution Agreement with Shanghai Universal Biotech Company
9. Shanghai CRO Service Alliance Adds Clinical Development Capabilities
10. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
11. Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference

Post Your Comments:

(Date:6/18/2013)... June 18, 2013 China Cord Blood Corporation ... China,s leading provider of cord blood collection, laboratory testing, ... today announced its preliminary unaudited financial results for the ... ended March 31, 2013. Fourth Quarter ... fourth quarter of fiscal 2013 increased by 33.3% to ...

(Date:6/18/2013)... PA (PRWEB) June 18, 2013 Demanding ... Ball Lenses engineered of synthetic Sapphire and Glass Ball ... sizes from Swiss Jewel Company , of Philadelphia ... by expanding and collimating the light beams without the ... optical clarity and natural durability (9 mohs) make it ...

(Date:6/18/2013)... RegeneCure announced today the start of a ... (GBR) Dental Membrane as a bone stimulating aid for patients ... patients have a tooth replaced with a dental implant is ... Consequently there is often a need to support the implant ... bone substitute material, in turn, needs to be held in ...

(Date:6/18/2013)... , June 18, 2013 AMRI (NASDAQ: ... Burlington, Mass. , site has ... Enforcement Administration (DEA) registration to handle Schedule 2 ... DEA,s acknowledgement of Burlington,s ... and documentation. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...

[0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors [0] RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants [0] AMRI Burlington Receives DEA Approval to Handle Controlled Substances

... 31 Savient,Pharmaceuticals, Inc. (Nasdaq: SVNT ) today ... and Drug Administration (FDA) seeking approval to,market pegloticase in ... review. Savient,s filing includes data from both the six-month,placebo ... from the Open,Label Extension (OLE) study. The data set ...

... 31 /Xinhua-PRNewswire/ -- Sundia MediTech,Company, a Shanghai-based drug ... this year,s Deloitte Technology,Fast 50 China award, and ... 50 China Program was announced today in Shenzhen, ... 50 Program started in 1995 in San Jose. ...

... than a dozen employers in health care, employment continued to increase in ... like no one was searching for those new jobs. , ... Seattle, ... care field, with an average of 30,000 jobs created each month. Even ...

Cached Biology Technology:Savient Submits Biologics License Application (BLA) for pegloticase 2 Savient Submits Biologics License Application (BLA) for pegloticase 3 Savient Submits Biologics License Application (BLA) for pegloticase 4 Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China 2 The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 2 The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 3

Savient Submits Biologics License Application (BLA) for pegloticase Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health

(Date:6/18/2013)... It is estimated that between 5% and 10% of ... is to say that these tumours are attributable to ... BRCA1 or BRCA2. In patients with these mutations, PARP ... encouraging results that make them a new option for ... the latest studies indicate that a fraction of these ...

(Date:6/18/2013)... LA, London (18 June 2013). A team of internationally ... by Dr Sarah Ellis from the University of Lincoln, ... Clinic, Wisconsin, U.S.A. were invited by the International Society ... Feline Practitioners (AAFP) to compile guidelines for veterinarians, owners ... the environmental needs of the domestic cat. The new ...

(Date:6/17/2013)... MA Women in the U.S. exposed to high levels ... likely to have a child with autism as women who ... study from Harvard School of Public Health (HSPH). It is ... and air pollution across the U.S. , "Our findings raise ... the women in our study lived in areas where risk ...

Breaking Biology News(10 mins):An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2 Feline behavior experts release guidelines to improve the welfare of cats 2 Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2

[0] An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer [0] Feline behavior experts release guidelines to improve the welfare of cats [0] Exposure to high pollution levels during pregnancy may increase risk of having child with autism

... April 14, 2011 -- The number of couples struggling with ... assisted reproductive technologies, like in vitro fertilization (IVF), to get ... increase the risk of multiple pregnancies (i.e., twins or triplets), ... Twins and triplets are likely to be born prematurely, ...

... 2011 Ceelox, Inc. (OTCBB: CELO) announced today that ... to cloud applications using biometrics. Ceelox ID Online® utilizes ... an Internet server-based biometric software application. This enables users ... credentials, i.e. user name and password, compromised or stolen ...

... The following highlights summarize research papers that have been ... 1. Little Ice Age resulted from more than just ... measure of the amount of light the Sun puts out, ... especially when TSI is notably higher or lower than its ...

Cached Biology News:New study finds stronger regulations of in vitro fertilization may save lives 2 Ceelox Provides Biometric Identity Access to Cloud Applications 2 Ceelox Provides Biometric Identity Access to Cloud Applications 3 AGU journal highlights -- April 13, 2011 2 AGU journal highlights -- April 13, 2011 3 AGU journal highlights -- April 13, 2011 4 AGU journal highlights -- April 13, 2011 5 AGU journal highlights -- April 13, 2011 6 AGU journal highlights -- April 13, 2011 7

New study finds stronger regulations of in vitro fertilization may save lives Ceelox Provides Biometric Identity Access to Cloud Applications AGU journal highlights -- April 13, 2011

...

BD BioCoat Collagen IV 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse collagen type IV....

... are designed for sequencing inserts cloned into ... or T3 RNA polymerase promoters, or lambda ... at a concentration of 0.1 µg/µl in ... DNA sequencing reactions using SequiTherm™ EXCEL™ II ...

BD BioCoat Matrigel Matrix 35 mm Culture Dishes Coating : BD MatrigelTM Basement Membrane Matrix ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vo...

Biology Products:

Eppendorf Thermomixer R from Eppendorf North America BD BioCoat Collagen IV 35 mm Culture Dishes from BD Biosciences - Discovery Labware Lambda GT11 Forward DNA Sequencing Primer from EPICENTRE Biotechnologies BD BioCoat Matrigel Matrix 35 mm Culture Dishes from BD Biosciences - Discovery Labware